SHOULDER INNOVATIONS, INC. Increase (Decrease) in Other Current Assets and Liabilities, Net
SHOULDER INNOVATIONS, INC. (SI) reported Increase (Decrease) in Other Current Assets and Liabilities, Net of -$908.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. increase (decrease) in other current assets and liabilities, net for the quarter ending 2026-06-30 was -$721.00K.
- SHOULDER INNOVATIONS, INC. increase (decrease) in other current assets and liabilities, net for the quarter ending 2026-03-31 was -$187.00K.
- SHOULDER INNOVATIONS, INC. increase (decrease) in other current assets and liabilities, net for the quarter ending 2025-12-31 was $821.00K.
- SHOULDER INNOVATIONS, INC. increase (decrease) in other current assets and liabilities, net for the quarter ending 2025-09-30 was -$769.00K, a 649.29% decline year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in other current assets and liabilities, net for fiscal 2025 was -$1.90M.
- SHOULDER INNOVATIONS, INC. increase (decrease) in other current assets and liabilities, net for fiscal 2024 was -$458.00K.
| Period end | Increase (Decrease) in Other Current Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Current Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$721.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$908.00K 10-Q · filed 2026-08-06 | -$87.00K derived: sum of 3 quarters · filed 2026-08-06 | -$856.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$187.00K 10-Q · filed 2026-05-13 | $634.00K derived: sum of 2 quarters · filed 2026-05-13 | -$135.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $52.00K derived: sum of 2 quarters · filed 2026-03-10 | -$1.13M derived: sum of 3 quarters · filed 2026-08-06 | -$1.90M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$769.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.95M derived: sum of 2 quarters · filed 2026-08-06 | -$2.72M 10-Q · filed 2025-11-12 | -$3.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.95M 10-Q · filed 2026-08-06 | -$2.37M derived: sum of 3 quarters · filed 2026-08-06 | -$2.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$769.00K 10-Q · filed 2026-05-13 | -$1.19M derived: sum of 2 quarters · filed 2026-05-13 | -$1.04M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$276.00K derived: sum of 2 quarters · filed 2026-03-10 | -$458.00K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$42.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$182.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |